PHARMA SA

Location

Iasi

Founded

2000-12-06

Risk Signals

21 news mentions monitored

Industry Context

This company is tracked across risk categories, including those related to its sector (e.g., Drugs, Drug Proprietaries, and Druggists' Sundries, Groceries and Related Products, Not Elsewhere Classified, Chemicals and Allied Products, Not Elsewhere Classified, Petroleum and Petroleum Products Wholesalers, Except Bulk Stations and Terminals, Nondurable Goods, Not Elsewhere Classified, Motor Vehicle Dealers (New and Used)), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.

Filter risk signals by topic

Select a theme below to explore the company’s news mentions in specific risk areas.

Recent Articles about PHARMA SA

Live alerts from global media, monitored by Business Radar

Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients

(businesswire.com)

Innate Pharma Announces Advancement of Sanofi-developed NK Cell Engager SAR443579 / IPH6101 Progressing to Phase 2 for Blood Cancer Patients

Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the first patient was dosed in the Pha...

Read more

Never miss a headline about PHARMA SA

Set up smart alerts with Business Radar and receive real-time updates on any new risk signal or major news story.

  • ✔️ Used by 100+ compliance teams and analysts
  • ✔️ Covers 154M+ sources in 40+ languages